pembrolizumab,bevacizumab
merck,roche
['gyn', 'bevacizumab', 'pembro']
pembro + chemotherapy w/ or w/o bevacizumab led to a substantial improvement in overall survival vs placebo plus chemotherapy with or without bevacizumab in pts with persistent, recurrent, or metastatic cervical cancer. #asco2023 #gyncsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.